With the China's entering to the WTO, the Chinese market will be more and more opened. More and more companies have got insight and started to focus on exploiting Chinese market because they know that the Chinese market is the largest potential market in the world. More than one hundred large pharmaceuticals companies including Pfizer, Eilly, Glaxo Wellcom, Novartis, Bayer, Merck, Smith-Kline Beecham, Daiichi, Pharmacia & Jpjohn have built their plants or established their business relationship with local Chinese pharmaceuticals companies in China.

Since there are different cultures between China and other foreign countries, some companies maybe feel it is a little bit difficult to step into the Chinese market. This causes a lot of companies to hesitate whether to exploit Chinese market now or later. But the opportunity only belongs to the one who step first. We are one of the best pharmaceutical products distributors in China. We have engaged in the area for many years and enjoying good reputation. Several imported products are being sold well such as Setus-M, Kerman Capsules. Now we are looking for the high-quality pharmaceuticals to meet the unmet need of both medical professionals and patients in China.

We understand that nowadays the collaboration is the key for business. One can't develop independently like before. Well -organized business cooperation will make big profit by half investment. So if you are a pharmaceuticals company with high-class products, and you want to take the opportunity to exploit Chinese market, please don't hesitate to contact us.